Tech Focus Asia
SEE OTHER BRANDS

Fresh science and technology news from Asia and the Pacific

Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on May 22, 2025

Minetek Sound Launches M-STEALTH Sound Attenuation: Revolutionising Mining and Industrial Noise Control

Minetek Sound Launches M-STEALTH Sound Attenuation: Revolutionising Mining and Industrial Noise Control

M-STEALTH is designed to deliver maximum noise reduction with minimal weight and components, preserving machine payloads and boosting productivity. SINGLETON, NEW SOUTH WALES, AUSTRALIA, May 23, 2025 /⁨EINPresswire.com⁩/ -- Minetek Sound, a global leader …

Just Superfund Transforms Client Support With Supportbench’s Customer Management Solution

Just Superfund Transforms Client Support With Supportbench’s Customer Management Solution

Australian accounting firm ends email chaos with Supportbench’s customer management tools VANCOUVER, BRITISH COLUMBIA, CANADA, May 22, 2025 /⁨EINPresswire.com⁩/ -- Just Superfund, a mid-sized accounting firm based in Australia, has transformed its client …

CONVERGE CFD Software Advances Simulation Tools for Aerospace, Automotive, Energy Sectors With Release of Version 5

CONVERGE CFD Software Advances Simulation Tools for Aerospace, Automotive, Energy Sectors With Release of Version 5

MADISON, WI, UNITED STATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- Convergent Science recently released CONVERGE 5, a new major version of their CONVERGE CFD software. The new version offers expanded modeling options for a wide range of industries and …

UltraSight™ Appoints Peter Chang Soo Kim to Board of Directors

UltraSight™ Appoints Peter Chang Soo Kim to Board of Directors

Global business leader brings 40+ years of leadership across insurance, healthcare, and institutional strategy BOSTON, MA, UNITED STATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- UltraSight™, a digital health leader using machine learning to transform cardiac …

The Cannata Report’s Annual Fundraiser to Benefit Diabetes Research at Hackensack University Medical Center Foundation

The Cannata Report’s Annual Fundraiser to Benefit Diabetes Research at Hackensack University Medical Center Foundation

40th Annual Anniversary Awards …

Gavel Unveils Gavel Exec: The Most Advanced AI Assistant for Small Law Firms

Gavel Unveils Gavel Exec: The Most Advanced AI Assistant for Small Law Firms

With agents integrated in Microsoft Word …

Entertainment Without Borders: AI-Media and Lightning International Join Forces to Make FAST Channels Accessible to Everyone

Entertainment Without Borders: AI-Media and Lightning International Join Forces to Make FAST Channels Accessible to Everyone

SYDNEY and HONG KONG, May 22, 2025 (GLOBE NEWSWIRE) -- AI-Media Technologies Limited ("AI-Media"), a global leader in live captioning and translation solutions, has entered a groundbreaking partnership with Lightning International ("Lightning"), the …

Imperial Announces Voting Results for the Election of Directors

Imperial Announces Voting Results for the Election of Directors

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial” or the “Company”) (TSX:III) reports, in accordance with the policies of the Toronto Stock Exchange, that the nominees listed in the management information …

Vortex Energy Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement

Vortex Energy Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) announces …

Award-Winning Designer Maryna Karpenko Honored for Shaping Consumer and B2B Experiences at Meta, Mattermost, Hily, and Wavechat

Award-Winning Designer Maryna Karpenko Honored for Shaping Consumer and B2B Experiences at Meta, Mattermost, Hily, and Wavechat

Award-winning product designer Maryna Karpenko is recognized for her leadership in shaping messaging and live-streaming experiences at Meta, Mattermost, Hily, and Wavechat. She has earned top industry honors for her work connecting millions of users …

Drilling Intersects 152.5 Metres Grading 0.46% Copper and 0.97 g/t Gold at Mount Polley

Drilling Intersects 152.5 Metres Grading 0.46% Copper and 0.97 g/t Gold at Mount Polley

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial” or the “Company”) (TSX:III) reports initial diamond drill results from the Mount Polley 2025 exploration program with a notable interval of 152.5 metres …

Maxus Mining Grants Incentive Stock Options

Maxus Mining Grants Incentive Stock Options

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM), is pleased to announce that it has granted an aggregate of 850,000 stock options (the “Options“) to members of its board of directors, …

Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome

Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome

REDWOOD CITY, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Soleno’s Marketing Authorization …

Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting

Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting

One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20% Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advanced Melanoma Previously Treated with Immune Checkpoint Inhibitor SAN CARLOS, …

Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC

Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC

-  63% response rate observed among 43 evaluable patients -  79% overall survival rate at 12-months; 9 months median progression-free survival -  Conference Call on Thursday, May 22 at 5:30 p.m. ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 22, …

Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting

Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting

– Results from KOMET-001 registration-directed trial of ziftomenib in R/R NPM1-m AML patients selected for oral presentation on Monday, June 2nd – – Encore presentation planned at EHA 2025 Congress – – Kura Oncology to host virtual investor event at 7:30pm …

PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Phase 2: Versamune® HPV with pembrolizumab as 1L treatment of r/m HPV16-positive HNSCC - Median overall survival for CPS ≥20 is 39.3 months - Median overall survival for CPS ≥1 is 30.0 months Phase 3: Versamune® HPV with pembrolizumab as 1L treatment of r/ …

IMUNON Announces Withdrawal of Form S-1 Registration Statement

IMUNON Announces Withdrawal of Form S-1 Registration Statement

LAWRENCEVILLE, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has filed a request for withdrawal with the Securities and …

Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel

Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel

SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …

ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025

ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025

ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025 ICT01 in combination with azacitidine and venetoclax (Aza-Ven) achieves unprecedented high remission rates overall and across molecular subtypes in newly …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service